Sprycel and Trilipix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprycel (dasatinib) and Trilipix (choline fenofibrate). Common drug interactions include pneumonia among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Sprycel and Trilipix. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Trilipix?

Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.



On Jul, 13, 2026

14 people who take Sprycel and Trilipix together, and have interactions are studied.

Sprycel and Trilipix drug interactions.

What are the common drug interactions of Sprycel and Trilipix, by gender? *:

female:

  1. Pneumonia
  2. Sinusitis (inflammation of sinus)
  3. Vomiting

male:

  1. Rash
  2. Arthralgia (joint pain)
  3. Oedema (fluid collection in tissue)
  4. Anaemia (lack of blood)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Swelling
  7. Pleural effusion (water on the lungs)
  8. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  9. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  10. Anxiety

What are the common drug interactions of Sprycel and Trilipix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Arthralgia (joint pain)
  2. Depression
  3. Anaemia (lack of blood)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Fatigue (feeling of tiredness)
  6. Oedema (fluid collection in tissue)
  7. Swelling
  8. Chest pain
  9. Leukaemia (blood or bone marrow cancer)
  10. Pneumonia

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 57.14%
  2. High Blood Pressure: 8 people, 57.14%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 57.14%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 50.00%
  5. Rickets (softening of bones): 7 people, 50.00%
  6. Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 50.00%
  7. Irritable Bowel Syndrome: 7 people, 50.00%
  8. Intervertebral Disc Protrusion (spinal disc protrusion): 7 people, 50.00%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 50.00%
  10. Diabetes: 7 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and Trilipix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sprycel and Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprycel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trilipix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib and choline fenofibrate (the active ingredients of Sprycel and Trilipix, respectively), and Sprycel and Trilipix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: